Rodríguez-Junquera, M.; Alén, A.; González-Urbistondo, F.; Rodríguez-Reguero, J.J.; Fernández, B.; Álvarez-Velasco, R.; Vazquez-Coto, D.; Vega-Prado, L.M.; Avanzas, P.; Coto, E.;
et al. A New High Penetrant Intronic Pathogenic Variant Related to Long QT Syndrome Type 2. J. Clin. Med. 2025, 14, 4646.
https://doi.org/10.3390/jcm14134646
AMA Style
Rodríguez-Junquera M, Alén A, González-Urbistondo F, Rodríguez-Reguero JJ, Fernández B, Álvarez-Velasco R, Vazquez-Coto D, Vega-Prado LM, Avanzas P, Coto E,
et al. A New High Penetrant Intronic Pathogenic Variant Related to Long QT Syndrome Type 2. Journal of Clinical Medicine. 2025; 14(13):4646.
https://doi.org/10.3390/jcm14134646
Chicago/Turabian Style
Rodríguez-Junquera, Manuel, Alberto Alén, Francisco González-Urbistondo, José Julián Rodríguez-Reguero, Bárbara Fernández, Rut Álvarez-Velasco, Daniel Vazquez-Coto, Lorena M. Vega-Prado, Pablo Avanzas, Eliecer Coto,
and et al. 2025. "A New High Penetrant Intronic Pathogenic Variant Related to Long QT Syndrome Type 2" Journal of Clinical Medicine 14, no. 13: 4646.
https://doi.org/10.3390/jcm14134646
APA Style
Rodríguez-Junquera, M., Alén, A., González-Urbistondo, F., Rodríguez-Reguero, J. J., Fernández, B., Álvarez-Velasco, R., Vazquez-Coto, D., Vega-Prado, L. M., Avanzas, P., Coto, E., Gómez, J., & Lorca, R.
(2025). A New High Penetrant Intronic Pathogenic Variant Related to Long QT Syndrome Type 2. Journal of Clinical Medicine, 14(13), 4646.
https://doi.org/10.3390/jcm14134646
